Convening of 80 leaders, researchers and staff across six colleges discussed strategies to address climate change mitigation, adaptation and societal transformation, in a Feb. 1 roundtable sponsored by The 2030 Project.
Researchers led by Cornell have discovered an unusual phenomenon in a metal-insulating material, providing valuable insights for the design of materials with new properties by way of faster switching between states of matter.
An experimental mRNA vaccine against human cytomegalovirus, a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any vaccine candidate, according to a study by Weill Cornell Medicine investigators.
According to Carl Cornell’s surname, one would think he was destined for the university. However, his path to Cornell has been anything but traditional. In this episode of the Inclusive Excellence Podcast, he joins Erin Sember-Chase to discuss his background and identities and how they have empowered him to ignite change across the university.
Students from the Brooks School’s State Policy Advocacy Clinic have teamed up with lawmakers and a community-based nonprofit representing formerly incarcerated mothers to introduce new legislation that would protect the rights of pre- and postnatal women in prisons and jails across New York.
Kersten, Ph.D. ’97, an experienced molecular nutrition researcher and academic leader, comes to Cornell from Wageningen University in the Netherlands, where he was most recently professor and chair of the Division of Human Nutrition and Health.
A multicenter, phase 3 clinical trial has found that apixaban is no more effective than aspirin at preventing a second stroke in patients diagnosed with a milder, related condition called atrial cardiopathy, according to new research.